CANDRIAM EQUITIES L ONCOLOGY IMPACT N-H |
|
|
DAX | 18.809,44 | -192,94 | -1,02% |
TecDax | 3.289,17 | -50,62 | -1,52% |
MDAX | 25.948,41 | -317,53 | -1,21% |
Dow Jones (EOD) | 42.025,19 | 522,09 | 1,26% |
Nasdaq 100 | 19.839,83 | 495,34 | 2,56% |
S & P 500 (EOD) | 5.713,64 | 95,38 | 1,70% |
SMI | 11.975,56 | -82,74 | -0,69% |
|
EUR/US$ | 1,1162 | 0,00 | -0,00% |
EUR/Yen | 160,6208 | 1,41 | 0,89% |
EUR/CHF | 0,9474 | 0,00 | 0,13% |
EUR/Brit. Pfund | 0,8395 | -0,00 | -0,09% |
Yen/US$ | 0,0069 | -0,00 | -0,71% |
CHF/US$ | 1,1781 | -0,00 | -0,11% |
|
baha Brent Indication | 73,82 | -0,40 | -0,53% |
Gold | 2.607,93 | 33,00 | 1,28% |
Silber | 31,33 | 0,19 | 0,61% |
Platin | 990,29 | 2,15 | 0,22% |
|
|
|